BIOTTS team
Biotechnology is our passion.

Paweł Biernat, PhD
CEO & Transdermal Systems Specialist

Co-founder and co-author of BIOTTS patents and therapeutic systems. Graduate, lecturer and assistant professor of the Medical University of Wrocław, the Faculty of Pharmacy; for 14 years gaining experience in the Chair and Department of Drugs Form Technology. Drug Form Technician; expert in the field of designing: nanocarriers of active substances, as well as transdermal and sterile, parenteral drug delivery systems. Author of numerous reports and scientific publications in Poland and abroad.

At Biotts, he is responsible for business development, selection of strategic products of the Company, creation of original formulas and the Company’s patent cloud.

Konrad Krajewski
Executive Vice President & CBO

Co-founder of Biotts S.A., since 2014 he specializes in building and developing medical startups. Graduate of Wrocław University of Science and Technology, Faculty of Information Technology and Enterprise Management. Co-founder of biotechnological company Genomtec inc and Terrabio Ilc. Certified International Project Manager of PRINCE2® and AgilePM® methodology. Expert in biotechnology business models.

Responsible for company management, business development, relations with investors and industry partners.

Karolina Buratyńska MBA
General Manager

Expert in building business strategies of pharmaceutical companies.

Experienced leader in the pharmaceutical market for over 13 years. Expert strategist in management positions responsible in the largest pharmaceutical companies. She gained her experience in Teva Pharmaceuticals, Valeant Pharmaceuticals, Sandoz and Nutricia. The business strategies she has implemented have been very successful on the market. She is a graduate of the Białystok University of Technology and Northampton University, where she received an MBA.

Jan Meler, PhD
Director of the Drug Development Department

Co-founder and co-author of BIOTTS patents and therapeutic systems.

Outstanding technologist in the area of dosage forms, for over 30 years associated with the Medical University of Wrocław in the Chair and Department of Drugs Form Technology. Responsible for the management and implementation of numerous scientific grants in the field of innovative production technologies, as well as the creation of products for the pharmaceutical, medical and cosmetics industry. Specialist and technologist of liquid and solid drug forms. Regional consultant for applied pharmacy and pharmacy. Author of over 170 scientific publications in Poland and abroad. He is passionate about natural prevention and treatment based on natural extracts.

At the Company, he is responsible for the development of new drugs, creation of systems for transporting active substances and solving problems in the pharmaceutical, cosmetics, food and chemical industries.

Dominik Marciniak, PhD Biostatistician

A PhD in pharmaceutical sciences, an assistant professor at the Department and Unit of Drug Form Technology, the head of the Biopharmaceutical Laboratory, and a coordinator of the Biopharmacy subject at the Faculty of Pharmacy at Wrocław Medical University. Starting from 2017, the Vice-President of Wrocław Branch of the Polish Pharmaceutical Society. An author and co-author of 63 scientific monographs and national and international reports. An experienced technologist of semi-solid drug forms, and a biopharmacy and biostatistics analyst.

Hanna Dopierała-Bartczak
Senior Drugs Form Specialist & Laboratory Manager

Hanna graduated cum laude in 2004 with M.Sc. in Chemistry from the Wroclaw University of Science and Technology. Since then, she has been a specialist and member of R&D teams at pharmaceutical companies. She is a highly experienced researcher, project manager and implementation specialist. Additionally, Hanna has gained expertise in preparing documentation for drug marketing authorisation procedures, creating pharmaceutical formulations and scaling production from lab to industrial scales

In Biotts, she is responsible for managing the R&D team and coordinating laboratory works.

 

Anna Szczepanik
Operating & finance manager

Graduate of the Wrocław University of Economics and postgraduate studies at the International University of Logistics and Transport in Wrocław. She managed and participated in numerous projects and processes of a chemical production company. Certified Project Manager of PRINCE2® Foundation methodology.

Responsible for administration and management of processes and finance at Biotts S.A.

Ewa Micewicz PhD
Head of preclinical research

Accomplished and result-oriented professional with experience in developing and managing comprehensive R&D programs within cancer biology and immunology. Experienced in drug development research aimed at the discovery of therapeutic entities, within anti-cancer, radiation biology, hormone replacement therapy, and antivirals fields. Expert in the development and application of animal models in the areas of cancer research, autoimmune diseases, obesity, and radiation biology. Experienced in ADME/PK studies for early stage preclinical development.

At Biotts, responsible for coordinating preclinical research.

Jerzy Wiśniewski PhD LC-MS/MS Specialist

Biotechnologist, researcher at the Wrocław University of Technology. For several years associated with the Medical University of Wrocław, where he defended his doctoral thesis and participated in many research and application projects. He is an expert in the field of chemical analysis, especially taking into account the technique of mass spectrometry coupled with liquid chromatography (LC-MS/MS). Co-author of many scientific publications and patent applications.

Katarzyna Romanowska
EU-Projektkoordinator

Graduate of the Wrocław Medical University, University of Economics and Université de Paris XIII, La Sorbonne (MHA). Since the beginning of her professional career she has been involved in health care and medicine. For over 10 years she has been specializing in team management, administration departments, as well as R&D projects in the biotechnology and medical sectors.

Paulina Topolska
Drugs Form Specialist & HPLC Expert

Aleksandra Pason
Junior Drugs Form Specialist

Biotechnology engineer, graduate student with a specialization in pharmaceutical biotechnology at the Faculty of Chemistry, Wrocław University of Technology. She has a certificate in monitoring and oversight of clinical trials.

Dawid Bursy Specialist drug form

A graduate of and a teacher at Wrocław Medical University, the Faculty of Pharmacy. A technologist of drug forms with experience in forming semi-solid dosage forms, he trains both students and graduates of the Faculty of Pharmacy in the field of sterile compounded formulations.

Agata Bluma
Junior lab & office assistant

Karolina Urban-Stojanowska
Assistant of preclinical research

Graduate of the Medical University of Wrocław, the Faculty of Pharmacy with the Division of Laboratory Diagnostics. Specialist in the field of nanocarriers of active substances. She has a certificate in the field of Clinical Research Monitoring.

Advisory Board

Erik Plas MSc.

Experienced executive with more than 25 years of experience in international business across various industries, especially in the pharmaceutical industry, where he held numerous positions of growing responsibility across many therapeutic areas. He was Managing Director of MSD Poland, Vice President of the local industry association INFARMA. A graduate from the Erasmus University of the Netherlands, Faculty of Rotterdam School of Management. Currently an entrepreneur, investor, consultant and expert in the development of medical companies, focusing on eHealth & Health Care, Biotech and Diagnostics.

 

Prof. Wiesław Gaweł, Ph.D., D.Sc.

A graduate of the Wrocław University of Technology, Faculty of Chemistry. Head of the Department of Analytical Chemistry, Faculty of Pharmacy, Wrocław Medical University. Research topics: analysis of biological and pharmaceutical materials, search for new drugs, phase studies on salt and metal binary systems. Author/co-author of ca. 130 publications in international journals, including papers at scientific conferences. Member of the elite organization (Associated Phase Diagram International Committee) of about 40 scientists from Central Europe countries.

In Biotts, he is a member of the Scientific Board, a scientific consultant, supporting works at the research and development stage.

Tomasz Poniński

Experienced expert in the area of investment and business development of technological projects. Chairman of the Supervisory Board of Biotts, managing partner in the VC Montis Capital fund. Since 2008 he has also held the position of President of the Management Board of Orenore Sp. z o. o., an investment company forming a capital group operating in the areas of life science/biotechnology and IT. He is the President of the Innovative.pl Foundation and an expert in commercialization at the BTM Innovations cluster and at the Institute of High Pressures of the Polish Academy of Sciences. He sat on the boards and supervisory boards of many listed companies, e.g. AirWayMedix S.A. and Adiuvo S.A., Chocolate Cambridge Technology S.A. Co-founder of Peptaderm technology projects, MarMar Investments, Glia, Netiology.

Valeri P. Melekhov, M.S., M.A.,MBA

Valeri is a pharma industry veteran with 35+ years of experience spanning from drugs technology licensing, drug development, business and corporate development, marketing research and corporate management.

During last 25 years he worked at one of the largest privately held pharmaceutical company in the USA where he was involved in marketing, sales, strategy, business model, business development and development of drug products including oral, transdermal and inhalation drug products. In addition to running his own business projects, Valeri sits of the Boards of Directors and Advisory Boards of several Pharma and high tech companies in the US.